- Home
- AVIR vs ZUMZ Comparison
AVIR vs ZUMZ Comparison
Compare AVIR & ZUMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- ZUMZ
- Stock Information
- Founded
- AVIR 2012
- ZUMZ 1978
- Country
- AVIR United States
- ZUMZ United States
- Employees
- AVIR N/A
- ZUMZ N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- ZUMZ Clothing/Shoe/Accessory Stores
- Sector
- AVIR Health Care
- ZUMZ Consumer Discretionary
- Exchange
- AVIR Nasdaq
- ZUMZ Nasdaq
- Market Cap
- AVIR 290.4M
- ZUMZ 343.6M
- IPO Year
- AVIR 2020
- ZUMZ 2005
- Fundamental
- Price
- AVIR $2.97
- ZUMZ $21.01
- Analyst Decision
- AVIR Hold
- ZUMZ Hold
- Analyst Count
- AVIR 1
- ZUMZ 1
- Target Price
- AVIR $6.00
- ZUMZ $18.00
- AVG Volume (30 Days)
- AVIR 223.7K
- ZUMZ 278.2K
- Earning Date
- AVIR 11-06-2025
- ZUMZ 09-04-2025
- Dividend Yield
- AVIR N/A
- ZUMZ N/A
- EPS Growth
- AVIR N/A
- ZUMZ N/A
- EPS
- AVIR N/A
- ZUMZ 0.03
- Revenue
- AVIR N/A
- ZUMZ $900,253,000.00
- Revenue This Year
- AVIR N/A
- ZUMZ $5.50
- Revenue Next Year
- AVIR N/A
- ZUMZ $1.36
- P/E Ratio
- AVIR N/A
- ZUMZ $614.40
- Revenue Growth
- AVIR N/A
- ZUMZ 1.64
- 52 Week Low
- AVIR $2.46
- ZUMZ $11.31
- 52 Week High
- AVIR $4.10
- ZUMZ $24.37
- Technical
- Relative Strength Index (RSI)
- AVIR 33.48
- ZUMZ 70.02
- Support Level
- AVIR $2.84
- ZUMZ $19.70
- Resistance Level
- AVIR $3.33
- ZUMZ $22.15
- Average True Range (ATR)
- AVIR 0.14
- ZUMZ 0.78
- MACD
- AVIR -0.04
- ZUMZ 0.01
- Stochastic Oscillator
- AVIR 18.98
- ZUMZ 78.41
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About ZUMZ Zumiez Inc.
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.